2WON

Crystal Structure of UK-453061 bound to HIV-1 Reverse Transcriptase (wild-type).

Summary for 2WON
Related1A30 1BV7 1BV9 1BVE 1BVG 1BWA 1BWB 1C0T 1C0U 1C1B 1C1C 1DMP 1DTQ 1DTT 1E6J 1EP4 1ESK 1EX4 1EXQ 1FB7 1FK9 1FKO 1FKP 1G6L 1HIV 1HVH 1HVR 1HWR 1HXB 1JKH 1JLA 1JLB 1JLC 1JLE 1JLF 1JLG 1JLQ 1KLM 1LV1 1LW0 1LW2 1LWC 1LWE 1LWF 1NCP 1O1W 1ODW 1ODY 1QBR 1QBS 1QBT 1QBU 1REV 1RT1 1RT2 1RT3 1RT4 1RT5 1RT6 1RT7 1RTD 1RTH 1RTI 1RTJ 1S1T 1S1U 1S1V 1S1W 1S1X 1T05 1TAM 1TKT 1TKX 1TKZ 1TL1 1TL3 1VRT 1VRU 3PHV
DescriptorHIV-1 REVERSE TRANSCRIPTASE, 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile (3 entities in total)
Functional Keywordsaids, non-nucleoside inhibitor, drug design, transferase, nnrti, sbdd
Biological sourceHUMAN IMMUNODEFICIENCY VIRUS 1
More
Cellular locationMatrix protein p17: Virion (Potential). Capsid protein p24: Virion (Potential). Nucleocapsid protein p7: Virion (Potential). Reverse transcriptase/ribonuclease H: Virion (Potential). Integrase: Virion (Potential): P04585 P04585
Total number of polymer chains2
Total formula weight116272.35
Authors
Phillips, C.,Irving, S.L.,Knoechel, T.,Ringrose, H. (deposition date: 2009-07-27, release date: 2010-08-11, Last modification date: 2011-07-13)
Primary citationCorbau, R.,Fishburn, L.,Irving, S.L.,Knoechel, T.,Martin, A.,Mori, J.,Mowbray, C.,Panton, W.,Perros, M.,Phillips, C.,Ringrose, H.,Smith-Burchnell, C.,Thornberry, A.,Westby, M.,Wood, A.
Lersivirine: A Non-Nucleoside Reverse Transcriptase Inhibitor with Activity Against Drug- Resistant Human Immunodeficiency Virus-1.
Antimicrob.Agents Chemother., 54:4451-, 2010
PubMed: 20660667
DOI: 110.1128/AAC.01455-09
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB Foundation
wwPDBRCSB PDBPDBeBMRBAdv. SearchSearch help

178747

PDB entries from 2021-06-09